Indications
Indicated to reduce cardiovascular risk as an adjunct to statin therapy.
Composition
- Active substance
- Icosapent ethyl
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Vazkepa
- Active substance
- Icosapent ethyl
- ATC code
- C10AX
- Therapeutic area
- Dyslipidemias
- Marketing authorisation holder
- Recordati Industria Chimica e Farmaceutica S.p.A.
- Status
- Authorised
- EU authorisation
- 26 Mar 2021
- EMA product number